OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PRLD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Prelude Therapeutics (PRLD) Earnings Date & Reports

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PRLD is expected to report earnings to fall 1.27% to -40 cents per share on November 18

Prelude Therapeutics PRLD Stock Earnings Reports

Q3'25

Est.

$-0.40

Q2'25

Beat

by $0.07

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.04

The last earnings report on August 14 showed earnings per share of -40 cents, beating the estimate of -47 cents. With 196.86K shares outstanding, the current market capitalization sits at 74.15M.

View a ticker or compare two or three

Compare

PRLD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PRLD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRLD showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

175 Innovation Boulevard

Phone

+1 302 467-1280

Employees

128

Web

https://www.preludetx.com